ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic
Accelerating COVID-19 Treatment Interventions and Vaccines (ACTIV) was initiated by the US government to rapidly develop and test vaccines and therapeutics against COVID-19 in 2020. The ACTIV Therapeutics-Clinical Working Group selected ACTIV trial teams and clinical networks to expeditiously develo...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cambridge University Press
2024-01-01
|
| Серии: | Journal of Clinical and Translational Science |
| Предметы: | |
| Online-ссылка: | https://www.cambridge.org/core/product/identifier/S2059866124000013/type/journal_article |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|